JCJoo-Hyung Choi

Joo-Hyung Choi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joo-Hyung Choi has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Improved immune responses and safety of foot-and-mouth disease vaccine containing immunostimulating components in pigs

    by Joo-Hyung Choi, Su-Hwa You, Mi-Kyeong Ko, Hye Eun Jo, Sung Ho Shin, Hyundong Jo, Min Ja Lee, Su-Mi Kim, Byounghan Kim, Jong-Soo Lee, et al.

    Choi JH, et al. J Vet Sci. 2019 Oct;21:e74. https://doi.org/10.4142/jvs.2020.21.e74


  • Open Access

    New foot-and-mouth disease vaccine, O JC-R, induce complete protection to pigs against SEA topotype viruses occurred in South Korea, 2014–2015

    by Hye-Eun Jo, Mi-Kyeong Ko, Joo-Hyung Choi, Sung Ho Shin, Hyundong Jo, Su-Hwa You, Min Ja Lee, Su-Mi Kim, Byounghan Kim, Jong-Hyeon Park

    Foot-and-mouth disease (FMD) is an acute epidemic that spreads rapidly among cattle and pigs. In 2014, in Korea, despite enforced vaccination, the type O Southeast Asia (SEA) topotype viruses (Mya-98 lineage) infected mainly cattle and pigs simultaneously, thereby causing enormous damage. If a vaccine that is completely protective against this FMD virus is developed and used, it can become a very important preventive measure in Asia, which is where this type of virus mainly circulates. The SEA topotype has been steadily evolving and transforming into new variations since it became epidemic in Asia. Therefore, it became necessary to develop a new vaccine that could provide protection against the FMD virus strain that was responsible for the 2014-2015 outbreak in Korea. This study aimed to develop a vaccine that would provide complete protection against the SEA topotype FMD virus to control sporadic FMD outbreaks, which occur despite the enforcement of vaccination, and to completely prevent virus shedding, thereby preventing the virus from spreading. The vaccine candidate virus developed in this study showed low pathogenicity and can be distinguished from the wild-type FMD virus strain. The developed vaccine was able to protect mice from SEA and Middle East-South Asia topotype virus strains and induced high titers of antibodies against both virus strains in pigs, thereby confirming the sufficiency of its protective function. In particular, the results of the SEA topotype virus challenge test in pigs revealed that perfect immunity was created in the vaccinated pigs, without virus shedding and viremia.